News
October 15, 2015Autumn Mix & Mingle to Benefit Cystic Fibrosis Research
Glowing fireplaces, fine spirits, cuisine and craft beers are on tap for the 2nd Annual Autumn Mix & Mingle to benefit the Cystic Fibrosis Foundation 7 p.m. on Saturday, October 24 at the Fort Orange Club in Albany. The festive fall evening will provide funds that are buying science and changing the course of cystic fibrosis. Register here!
Guests will enjoy fine cuisine, extensive tastings of wines, champagnes, ports, scotches, whiskeys, tequila, bourbons, ryes, cognacs and a selection of crafts beers. The New York Players, will set the mood providing lively entertainment with dancing into the evening. Unique items, sports memorabilia, jewelry, airfare are just some of the items features in a silent auction.
“We are proud to support the Cystic Fibrosis Foundation through Autumn Mix & Mingle”, said LynnMarie Paris-Frangie, event co-chair. “We are dedicated to cystic fibrosis fund raisers like this one, that will continue to provide the Foundation the financial resources needed to invest in new drug development”, said Nehme Frangie, event co-chair.
There has been significant progress in recent months in CF therapies. Just this summer, the FDA approved the 2nd ever drug that treats the disease, not the symptoms. Orkambi, by Vertex Pharmaceuticals, treats half of those with cystic fibrosis (with the most common CF mutation).
In 2012, Kalydeco – another drug funded by the CF Foundation and produced by Vertex, treats 4% of those with specific CF mutations.
CF is a genetic disease affecting 30,000 children and adults in the United States. It causes the body to produce abnormally thick, sticky mucus, which leads to chronic and life-threatening lung infections that lead to an untimely death. Since 1955 when the Foundation was established, the mission of the Cystic Fibrosis Foundation, a nonprofit donor-supported organization, has been to assure the development of the means to cure and control cystic fibrosis and to improve the quality of life for those with the disease.
